Die neuesten CLDX Reports werden am 2024-05-06 aktualisiert: 2024-Q12023-Q42023-Q1
Celldex Therapeutics logo
Celldex Therapeutics CLDX
€ 38.10 -0.36%

Celldex Therapeutics Kennzahlen 2011-2024 | CLDX

Kennzahlen Jährlich Celldex Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.0 -0.0 -0.0 -0.0 -0.7 -0.4 -3.9 -2.6 -6.3 -16.2 -25.8 -7.1 -4.0

P/S

0.3 0.8 0.3 0.1 9.4 6.7 28.2 48.6 147.0 534.0 512.5 37.5 19.1

EPS

-2.9 -2.4 -1.6 -2.0 -3.5 -14.5 -0.7 -1.3 -1.3 -1.3 -1.0 -1.0 -1.1

EV (Enterprise Value)

3.97 M -895 K -12.6 M -16.7 M 51.2 M 71.7 M 399 M 405 M 781 M 1.92 B 1.96 B 425 M 195 M

EBITDA per Share

-3.13 K -2.4 K -1.59 K -2 K -3.42 -7.3 -12.7 -19.5 -19.9 -20.4 -15.1 -14.8 -15.8

EV/EBITDA

0.2 -5.9 -0.4 -0.6 -3.0 -2.2 -5.7 -15.6 -24.1 -7.1 -4.4

PEG

-0.0 -0.0 -0.0 -0.0 -0.01 0.01 -0.09 -0.84 -8.36 0.55 2.7 -0.73 0.0

P/B

0.0 0.0 0.0 0.0 0.4 0.5 1.5 1.2 2.8 9.0 6.6 4.4 2.6

P/CF

-0.0 -0.0 -0.0 -0.0 -0.7 -0.8 -3.5 -2.8 -7.8 -18.5 -29.3 -8.4 -4.9

ROE %

-32.95 -34.43 -16.81 -28.55 -54.11 -121.86 -39.36 -48.42 -43.85 -55.79 -25.50 -61.73 -65.19

ROA %

-30.37 -31.84 -15.86 -25.35 -41.39 -97.03 -29.48 -33.53 -37.68 -47.61 -23.50 -47.09 -45.72

ROCE %

-36.01 -35.33 -16.98 -30.26 -48.99 -53.35 -37.98 -38.18 -42.15 -54.77 -24.93 -53.85 -51.91

Current Ratio

12.8 13.3 17.7 8.9 5.7 7.9 5.2 5.6 9.8 8.4 15.0 4.8 3.8

DSO

78.9 40.2 77.5 69.3 103.7 121.0 53.8 96.0 64.6 43.5 43.4 1.4 6.7

DIO

- - - - - - - - - - - - -

DPO

4157.4 8336.6 4153.7 2027.6 - - - - - - 350.8 25.2 37.4

Betriebszyklus

78.9 40.2 77.5 69.3 - - - - - - 43.4 1.4 6.7

Finanzkreislauf

-4078.5 -8296.4 -4076.2 -1958.3 - - - - - - -307.4 -23.8 -30.7

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Celldex Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.56 - -0.81 -0.65 -0.62 - -0.57 -0.77 -0.49 - -0.45 -0.34 -0.42 -0.55 -0.36 -0.5 -0.73 -0.64 -0.75 -0.84 -1.4 -0.81 -0.66 -1.67 -12.61 -0.42 -3.05 -3.42 -4.19 -0.3 -0.29 -0.32 -0.35 -0.33 -0.32 -0.33 -0.33 -0.36 -0.31 -0.32 -0.33 -0.27 -0.29 -0.24 -0.23 -0.27 -0.25 -0.23 -0.27 -0.29 -0.27 -0.27 -0.31

EBITDA per Share

-677 - - - -672 - -543 -745 -480 - -0.41 -0.3 -0.4 - -0.28 -0.41 -0.67 - -0.53 -0.7 -1.35 - -0.45 -1.72 -12.7 - -0.22 -0.21 -0.28 - -0.28 -0.31 -0.35 - -0.31 -0.32 -0.33 - -0.32 -0.31 -0.35 - -0.27 -0.22 -0.23 - -0.22 -0.21 -0.25 - -0.22 -0.23 -0.28

ROE %

-45.92 -36.20 -43.95 -36.20 -35.07 -23.41 -28.09 -25.02 -22.49 -20.54 -31.00 -33.11 -31.04 -28.55 -29.20 -34.55 -41.81 -54.11 -50.58 -44.28 -44.98 -121.86 -115.91 -121.23 -120.09 -39.36 -49.90 -49.90 -49.85 -48.42 -47.52 -47.39 -46.51 -43.85 -47.61 -49.86 -52.06 -55.79 -47.65 -41.62 -34.21 -25.50 -36.15 -44.60 -53.04 -61.73 -62.71 -64.15 -64.66 -65.19 -17.13 -14.89 -14.64

ROA %

-41.27 -32.89 -40.14 -33.75 -32.49 -21.62 -26.07 -23.26 -20.86 -18.53 -27.82 -29.40 -27.54 -25.35 -24.56 -27.81 -32.72 -41.39 -38.92 -34.29 -35.24 -97.03 -92.21 -95.92 -94.44 -29.48 -36.69 -36.05 -35.34 -33.53 -34.78 -36.53 -37.78 -37.68 -40.83 -42.68 -44.49 -47.61 -41.14 -36.48 -30.56 -23.50 -30.53 -35.83 -41.32 -47.09 -46.70 -46.74 -46.22 -45.72 -12.01 -10.45 -10.26

ROCE %

-50.24 -39.40 -47.42 -38.73 -36.73 -23.83 -28.60 -25.35 -22.75 -20.71 -27.56 -29.64 -27.70 -18.42 -31.02 -36.77 -44.37 -44.71 -50.97 -44.63 -45.20 -116.33 -129.85 -137.11 -135.75 -40.61 -51.91 -49.69 -49.65 -36.94 -48.10 -47.96 -47.06 -33.13 -47.46 -50.64 -52.84 -42.70 -49.98 -42.92 -35.26 -18.55 -33.95 -42.08 -50.33 -43.36 -60.06 -61.36 -61.66 -45.13 -16.70 -14.38 -14.05

Current Ratio

28.7 12.8 8.4 13.8 14.9 13.3 15.5 10.6 16.4 17.7 19.6 9.2 8.8 8.9 8.9 8.9 8.9 4.2 4.2 4.2 4.2 4.9 4.9 4.9 4.9 4.0 4.0 4.0 4.0 3.2 3.2 3.2 3.2 7.1 7.1 7.1 7.1 6.8 6.8 6.8 6.8 12.7 12.7 12.7 12.7 4.2 4.2 4.2 4.2 3.4 3.4 3.4 3.4

DSO

1549.8 - 11.1 243.8 78.4 - 32.1 95.2 108.8 - 206.7 30.5 241.8 43.4 246.2 696.8 47.1 104.4 169.6 129.5 133.7 163.6 306.6 104.4 56.5 49.6 43.7 44.8 109.0 86.9 73.3 117.2 96.4 49.5 86.3 40.6 131.2 26.4 35.4 65.8 100.5 72.0 45.5 460.0 10.1 1.1 1.3 2.0 4.0 6.4 6.6 8.0 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

1549.8 - 11.1 243.8 78.4 - 32.1 95.2 108.8 - 206.7 30.5 241.8 43.4 246.2 696.8 47.1 104.4 169.6 129.5 133.7 163.6 306.6 104.4 56.5 49.6 43.7 44.8 109.0 86.9 73.3 117.2 96.4 49.5 86.3 40.6 131.2 26.4 35.4 65.8 100.5 72.0 45.5 460.0 10.1 1.1 1.3 2.0 4.0 6.4 6.6 8.0 -

Finanzkreislauf

1549.8 - 11.1 243.8 78.4 - 32.1 95.2 108.8 - 206.7 30.5 241.8 43.4 246.2 696.8 47.1 104.4 169.6 129.5 133.7 163.6 306.6 104.4 56.5 49.6 43.7 44.8 109.0 86.9 73.3 117.2 96.4 49.5 86.3 40.6 131.2 26.4 35.4 65.8 100.5 72.0 45.5 460.0 10.1 1.1 1.3 2.0 4.0 6.4 6.6 8.0 -

Alle Zahlen in USD-Währung